000078 海王生物
2023/09 - 九个月2022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)1.870-19.5451.595-4.7603.373
总资产报酬率 ROA (%)0.245-2.7820.241-0.7130.502
投入资产回报率 ROIC (%)0.444-4.9480.409-1.2210.756

边际利润分析
销售毛利率 (%)10.32310.01710.71311.61213.306
营业利润率 (%)1.150-2.2591.3670.7912.238
息税前利润/营业总收入 (%)3.2460.1383.3702.8934.797
净利润/营业总收入 (%)0.649-2.6220.628-0.1031.241

收益指标分析
经营活动净收益/利润总额(%)87.792-6.142126.015329.717130.514
价值变动净收益/利润总额(%)7.63510.15713.02025.15521.517
营业外收支净额/利润总额(%)3.677-0.1672.654-18.373-5.964

偿债能力分析
流动比率 (X)1.0671.0621.0621.0551.086
速动比率 (X)0.9490.9200.9350.9330.969
资产负债率 (%)82.82283.14580.56581.14480.930
带息债务/全部投入资本 (%)75.69875.52071.744--74.200
股东权益/带息债务 (%)31.42231.34137.38932.86534.057
股东权益/负债合计 (%)15.99515.56319.21818.24018.778
利息保障倍数 (X)1.5820.0581.7141.3001.787

营运能力分析
应收账款周转天数 (天)182.918179.857156.6360.000160.537
存货周转天数 (天)40.28842.22337.8030.00038.402